Authors: DURELLI L SARACCO G RIZZETTO M PAGNI R VERDUN E BONGIOANNI MR BERGAMASCO B

Citation: L. Durelli et al., AUTOIMMUNE SIDE-EFFECT PROFILE DURING CHRONIC INTERFERON (IFN) THERAPY FOR MULTIPLE-SCLEROSIS (MS), Neurology, 48(3), 1997, pp. 4076-4076

Authors: BONGIOANNI MR DURELLI L FERRERO B IMPERIALE D OGGERO A VERDUN E AIMO G PAGNI R GEUNA M BERGAMASCO B

Citation: Mr. Bongioanni et al., SYSTEMIC HIGH-DOSE RECOMBINANT-ALPHA-2A-INTERFERON THERAPY MODULATES LYMPHOKINE PRODUCTION IN MULTIPLE-SCLEROSIS, Journal of the neurological sciences, 143(1-2), 1996, pp. 91-99

Authors: DURELLI L BONGIOANNI MR FERRERO B VERDUN E RIVA A GUENA M BRADAC GB BERGAMASCO B BERGAMINI L

Citation: L. Durelli et al., CHRONIC ALFA INTERFERON (IFNA) TREATMENT FOR MULTIPLE-SCLEROSIS (MS) MODULATES CYTOKINE PRODUCTION RATHER THAN ANTIGEN PRESENTATION PROCESS, Neurology, 45(4), 1995, pp. 234-234

Authors: FERRERO B DURELLI L BONGIOANNI MR AIMO G VERDUN E BERGAMASCO B

Citation: B. Ferrero et al., DECREASED ANTIACETYLCHOLINE RECEPTOR ANTIBODY (ACHR AB) BINDING AVIDITY AFTER HIGH-DOSE GAMMA-GLOBULIN (HIG) CORRELATES WITH CLINICAL EFFICACY IN MYASTHENIA-GRAVIS (MG), Neurology, 45(4), 1995, pp. 283-284